These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
419 related articles for article (PubMed ID: 17302875)
1. Potentiating effects of nonactive/active vitamin D analogues and ketoconazole in parathyroid cells. Segersten U; Björklund P; Hellman P; Akerström G; Westin G Clin Endocrinol (Oxf); 2007 Mar; 66(3):399-404. PubMed ID: 17302875 [TBL] [Abstract][Full Text] [Related]
2. 25-Hydroxyvitamin D3 1alpha-hydroxylase expression in breast cancer and use of non-1alpha-hydroxylated vitamin D analogue. Segersten U; Holm PK; Björklund P; Hessman O; Nordgren H; Binderup L; Akerström G; Hellman P; Westin G Breast Cancer Res; 2005; 7(6):R980-6. PubMed ID: 16280049 [TBL] [Abstract][Full Text] [Related]
3. 25-Hydroxyvitamin D(3) suppresses PTH synthesis and secretion by bovine parathyroid cells. Ritter CS; Armbrecht HJ; Slatopolsky E; Brown AJ Kidney Int; 2006 Aug; 70(4):654-9. PubMed ID: 16807549 [TBL] [Abstract][Full Text] [Related]
4. The vitamin D prodrugs 1alpha(OH)D2, 1alpha(OH)D3 and BCI-210 suppress PTH secretion by bovine parathyroid cells. Brown AJ; Ritter CS; Knutson JC; Strugnell SA Nephrol Dial Transplant; 2006 Mar; 21(3):644-50. PubMed ID: 16221703 [TBL] [Abstract][Full Text] [Related]
6. Constitutive expression of 25-hydroxyvitamin D3-1alpha-hydroxylase in a transformed human proximal tubule cell line: evidence for direct regulation of vitamin D metabolism by calcium. Bland R; Walker EA; Hughes SV; Stewart PM; Hewison M Endocrinology; 1999 May; 140(5):2027-34. PubMed ID: 10218951 [TBL] [Abstract][Full Text] [Related]
7. Increased 25-hydroxyvitamin D3 1alpha-hydroxylase and reduced 25-hydroxyvitamin D3 24-hydroxylase expression in parathyroid tumors--new prospects for treatment of hyperparathyroidism with vitamin d. Correa P; Segersten U; Hellman P; Akerstrom G; Westin G J Clin Endocrinol Metab; 2002 Dec; 87(12):5826-9. PubMed ID: 12466393 [TBL] [Abstract][Full Text] [Related]
9. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis. Brandi L Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159 [TBL] [Abstract][Full Text] [Related]
10. Predominant role of 25OHD in the negative regulation of PTH expression: clinical relevance for hypovitaminosis D. Kawahara M; Iwasaki Y; Sakaguchi K; Taguchi T; Nishiyama M; Nigawara T; Tsugita M; Kambayashi M; Suda T; Hashimoto K Life Sci; 2008 Mar; 82(13-14):677-83. PubMed ID: 18304585 [TBL] [Abstract][Full Text] [Related]
12. 1Alpha,25-dihydroxy-3-epi-vitamin D3, a natural metabolite of 1alpha,25-dihydroxyvitamin D3, is a potent suppressor of parathyroid hormone secretion. Brown AJ; Ritter C; Slatopolsky E; Muralidharan KR; Okamura WH; Reddy GS J Cell Biochem; 1999 Apr; 73(1):106-13. PubMed ID: 10088729 [TBL] [Abstract][Full Text] [Related]
13. Hormonal regulation of 25-hydroxyvitamin D3-1alpha-hydroxylase and 24-hydroxylase gene transcription in opossum kidney cells. Armbrecht HJ; Hodam TL; Boltz MA Arch Biochem Biophys; 2003 Jan; 409(2):298-304. PubMed ID: 12504896 [TBL] [Abstract][Full Text] [Related]
14. Altered pharmacokinetics of 1alpha,25-dihydroxyvitamin D3 and 25-hydroxyvitamin D3 in the blood and tissues of the 25-hydroxyvitamin D-24-hydroxylase (Cyp24a1) null mouse. Masuda S; Byford V; Arabian A; Sakai Y; Demay MB; St-Arnaud R; Jones G Endocrinology; 2005 Feb; 146(2):825-34. PubMed ID: 15498883 [TBL] [Abstract][Full Text] [Related]
15. Clonal differences in expression of 25-hydroxyvitamin D(3)-1alpha-hydroxylase, of 25-hydroxyvitamin D(3)-24-hydroxylase, and of the vitamin D receptor in human colon carcinoma cells: effects of epidermal growth factor and 1alpha,25-dihydroxyvitamin D(3). Bareis P; Kállay E; Bischof MG; Bises G; Hofer H; Pötzi C; Manhardt T; Bland R; Cross HS Exp Cell Res; 2002 Jun; 276(2):320-7. PubMed ID: 12027461 [TBL] [Abstract][Full Text] [Related]
16. A 24-phenylsulfone analog of vitamin D inhibits 1alpha,25-dihydroxyvitamin D(3) degradation in vitamin D metabolism-competent cells. Lechner D; Manhardt T; Bajna E; Posner GH; Cross HS J Pharmacol Exp Ther; 2007 Mar; 320(3):1119-26. PubMed ID: 17182978 [TBL] [Abstract][Full Text] [Related]
17. Regulation of messenger ribonucleic acid expression of 1 alpha,25-dihydroxyvitamin D3-24-hydroxylase in rat osteoblasts. Nishimura A; Shinki T; Jin CH; Ohyama Y; Noshiro M; Okuda K; Suda T Endocrinology; 1994 Apr; 134(4):1794-9. PubMed ID: 8137744 [TBL] [Abstract][Full Text] [Related]
18. 25-hydroxyvitamin D(3)-1alpha-hydroxylase expression in normal and pathological parathyroid glands. Segersten U; Correa P; Hewison M; Hellman P; Dralle H; Carling T; Akerström G; Westin G J Clin Endocrinol Metab; 2002 Jun; 87(6):2967-72. PubMed ID: 12050281 [TBL] [Abstract][Full Text] [Related]
19. 25-Hydroxyvitamin D(3) is an agonistic vitamin D receptor ligand. Lou YR; Molnár F; Peräkylä M; Qiao S; Kalueff AV; St-Arnaud R; Carlberg C; Tuohimaa P J Steroid Biochem Mol Biol; 2010 Feb; 118(3):162-70. PubMed ID: 19944755 [TBL] [Abstract][Full Text] [Related]
20. Suppression of PTH by the vitamin D analog eldecalcitol is modulated by its high affinity for the serum vitamin D-binding protein and resistance to metabolism. Ritter CS; Brown AJ J Cell Biochem; 2011 May; 112(5):1348-52. PubMed ID: 21337382 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]